Experimental Oncology, 2013, № 2
Постійний URI цієї колекціїhttps://nasplib.isofts.kiev.ua/handle/123456789/133136
ЗМІСТ
ORIGINAL CONTRIBUTIONS
-
Gerashchenko O.L., Zhuravel E.V., Skachkova O.V., Khranovska N.N., Filonenko V.V., Pogrebnoy P.V., Soldatkina M.A.
Biologic activities of recombinant human-beta-defensin-4 toward cultured human cancer cells
Sarnatskaya V.V., Sidorenko A.S., Klymchuk D.A., Khohulya I.M., Yushko L.A., Maslenniy V.N., Nikolaev V.G.
Optimization of physico-chemical properties of carbon enterosorbents and evaluation of their sorption activity for use in the treatment of paraneoplastic syndrome and other endogenous intoxications in cancer patients
Smorodin E.P., Kurtenkov O.A., Sergeyev B.L.
The level of anti-(galnac beta) and anti-para-forssman disaccharide igg antibodies in patients with gastrointestinal cancer: relation to survival
Sultanova A., Chistjakovs M., Chapenko S., Donina S., Murovska M.
Possible interference of human beta-herpesviruses-6 and -7 in gastrointestinal cancer development
Subramanyam D., Subbaiah K.C.V., Rajendra W., Lokanatha V.
Serum selenium concentration and antioxidant activity in cervical cancer patients before and after treatment
Fishchuk L.E., Gorovenko N.G.
Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
Kobys V.L., Konovalenko V.F., Repinа N.V., Golovko T.S., Gulak L.O., Tarasova T.O., Zaharycheva E.V., Matyushok O.F.
Treatment of large osteosarcoma in children: new approach
Skachkova O.V., Khranovska N.M., Gorbach O.I., Svergun N.M., Sydor R.I., Nikulina V.V.
Immunological markers of anti-tumor dendritic cells vaccine efficiency in patients with non-small cell lung cancer
Vernygorodskyi S.
Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach
Svintsitskiy V.S., Vorobyova L.I., Klymenko E.S., Dermenzhy T.V., Tkalya J.G.
Recurrence of borderline ovarian tumors
Giesel F.L., Flechsig P., Kuder T., Schwartz L., Wulfert S., Zechmann C., Bruchertseifer F., Haberkorn U., Kratochwil C.
Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177LU/90Y-DOTATOC and 213BI-DOTATOC radiopeptide therapy